Jie-Wen Zhang

Jie-Wen Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SCShuai Chen
Shuai Chen
XFXiao-Rui Fan
Xiao-Rui Fan
SHShuang He
Shuang He
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li

1 October 2014 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SCShuai Chen
Shuai Chen
MGMin Guan
Min Guan
HLHao-Jun Lian
Hao-Jun Lian
LMLi-Jia Ma
Li-Jia Ma
JSJun-Kui Shang
Jun-Kui Shang
JZJie-Wen Zhang
Jie-Wen Zhang

26 August 2024 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SCShuai Chen
Shuai Chen
MWMeng-Yun Wang
Meng-Yun Wang
JSJing-Yu Shao
Jing-Yu Shao
HYHong-Qi Yang
Hong-Qi Yang
HZHong-Ju Zhang
Hong-Ju Zhang
JZJie-Wen Zhang
Jie-Wen Zhang

1 June 2018 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
SHShuang He
Shuang He
SCShuai Chen
Shuai Chen
MXMing-Rong Xia
Ming-Rong Xia
ZSZhi-Kun Sun
Zhi-Kun Sun
YHYue Huang
Yue Huang
JZJie-Wen Zhang
Jie-Wen Zhang

Background and purpose:
Frontotemporal dementia (FTD) is the second most common presenile dementia characterized by behavioral changes and language impairment. The diagnosis of FTD relies heavily on neuroimaging, and sometimes on genetic screening. However, the genetic components in Chinese FTD patients remain largely unknown. Only a few FTD cases with established mutations have been reported in China. This study reported the detailed clinical and neuroimaging features in a Chinese behavioral variant FTD family. The role of MAPT gene mutation in Chinese dementia patients was also reviewed. Methods: By detailed inquiry of all affected individuals in the family, this study summarized the main clinical features of the disease. Four candidate genes (MAPT, PSEN1, PSEN2, and APP) were screened by direct sequencing. Structural magnetic resonance imaging (MRI), functional imaging of cerebral blood flow with arterial spin-labeled MRI (ASL-MRI), and cerebral metabolism with fluorodeoxyglucose positron emission tomography (FDG-PET) were collected in the proband and healthy mutation carriers. Results: By direct sequencing of candidate genes (MAPT, PSEN1, PSEN2, and APP), this study identified the P301L mutation in the MAPT gene in the proband and three unaffected family members. The phenotype of the affected cases was consistent within the pedigree. In this genetically proven behavioral variant FTD (bvFTD) patient, the maps of hypoperfusion on ASL-MRI look fairly similar to the hypometabolism on FDG-PET. The clinical feature for this bvFTD was in line with the hypoperfusion or hypometabolism pattern on functional neuroimagings. The phenotype of P301L in east Asia seems similar to western countries. Conclusion: For the inherited FTD patients, ASL-MRI and genetic identification were strongly recommended for the final diagnosis. In case of being underestimated, the role of MAPT gene mutation in Chinese FTD patients warrants further investigation.

22 October 2019 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
SCShuai Chen
Shuai Chen
SHShuang He
Shuang He
YXYin-Yan Xu
Yin-Yan Xu
HTHai-Ying Teng
Hai-Ying Teng
JZJie-Wen Zhang
Jie-Wen Zhang
The clinical presentation in Chinese patients with sporadic Creutzfeldt-Jakob disease (sCJD) may be unique due to the big difference in the codon 129 polymorphism of the prion protein gene (PRNP). This study retrospectively reviewed 26 cases of sCJD diagnosed in a single center in recent years. All 26 sCJD patients received brain magnetic resonance imaging scan, cerebrospinal fluid 14-3-3 protein detection, electroencephalogram, and PRNP gene screening. The codon 129 polymorphism were all homozygous MM in 26 sCJD patients. The main onset symptoms of sCJD patients were rapidly progressive dementia, visual impairment, and cerebellar ataxia. At the time of diagnosis, the incidence of myoclonus and akinetic mutism were relatively low (<50%). For auxiliary examinations, the positive rate of the typical magnetic resonance imaging (MRI) abnormalities, cerebrospinal fluid 14-3-3 protein, and electroencephalogram-periodic sharp wave complex was 96%, 64%, and 50%, respectively. As MM genotype is dominant and brain MRI is sensitive, brain MRI seems to play a major role in diagnosis of sCJD in Chinese.

3 November 2021 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
SCShuai Chen
Shuai Chen
JZJin‐Long Zou
Jin‐Long Zou
SHShuang He
Shuang He
WLWei Li
Wei Li
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li
Objective: Hereditary spastic paraplegia (HSP) due to ERLIN2 gene mutations was designated as spastic paraplegia 18 (SPG18). To date, SPG18 families/cases are still rarely reported. All early reported cases shared the autosomal recessive (AR) inheritance pattern. Over the past 3 years, autosomal dominant (AD) or sporadic SPG18 cases had been continuously reported. Here, we reported the clinical and genetic features of the first autosomal dominant SPG18 pedigree in Chinese.Methods: We conducted detailed medical history inquiry, neurological examinations of the proband and his family members, and charted the family tree. The proband underwent brain and cervical magnetic resonance imaging (MRI), electromyography (EMG), and whole exome sequencing. Sanger sequencing was performed to verify the genetic variation in the proband and some family members. A literature review of all reported SPG18 families/cases was carried out to summarize the clinical‐genetic characteristics of SPG18 under different inheritance patterns.Results: Four patients were clinically diagnosed as chronic spastic paraplegia in three consecutive generations with the autosomal dominant inheritance model. All the patients presented juvenile‐adolescent onset and gradually worsening pure HSP phenotype. Clinical phenotypes were consistent within the family. Whole exome sequencing in the proband identified a previously reported heterozygous c.502G > A (p.V168M) mutation in exon 8 of ERLIN2 gene. This mutation was cosegregated with the phenotype in the family and was classified as likely pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines. To date, eight AR‐SPG18 families, five AD‐SPG18 families, and three sporadic cases had been reported. Clinical phenotype of AD‐SPG18 was juvenile‐adolescent onset pure HSP, while the phenotype of AR‐SPG18 was mostly complicated HSP with earlier onset and more severe conditions. In rare cases, the initial spastic paraplegia could evolve to rapidly progressive amyotrophic lateral sclerosis (ALS).Conclusions: We reported the first autosomal dominant SPG18 pedigree in Chinese Han population, which added more pathogenic evidence for V168M mutation. As more SPG18 cases reported, the essentials of SPG18 need to be updated in clinical practice. Special attentions should be given in gene test for upper motor neuron disorders in case of missing heterozygous mutations in ERLIN2.